Radium has no standard commodity price today because it is not bought and sold on any open market. In the early twentieth century, a single gram of radium element cost roughly $100,000, making it one of the most expensive substances on Earth at the time. The only form of radium with a meaningful modern price tag is radium-223 dichloride, a pharmaceutical used in cancer treatment, where the cost runs into tens of thousands of dollars per patient course. The story of radium’s price is really a story of how a substance went from the most coveted material in science to something too dangerous and too regulated to trade freely.
The Staggering Early Price Tag
When Marie and Pierre Curie isolated radium in the late 1890s, the quantities were vanishingly small, extracted through grueling chemical processing of uranium ore. Commercialization was slow, and the price reflected just how difficult it was to produce even tiny amounts. By 1910, radium element cost about $100,000 per gram. To put that in perspective, the famous Hope Diamond sold the year before for around $80,060, which works out to roughly $8,800 per gram of gemstone. Gram for gram, radium was more than ten times as expensive as one of the most storied diamonds in history.1Elements. Just One Gram: A Radium Odyssey
Adjusted for inflation, that 1910 price translates to something in the range of $3 million per gram in today’s dollars. The comparison sounds absurd until you consider what it took to get that gram: tons of pitchblende ore had to be hauled, crushed, dissolved in acid, and run through a long chain of chemical separations. The yield was microscopic. Marie Curie famously processed several tons of ore to obtain a fraction of a gram for her Nobel Prize-winning research.
How Monopolies Shaped the Supply
Radium’s price did not stay at its 1910 peak forever, but the drops had less to do with improved chemistry than with who controlled the ore. The earliest commercial radium came from mines in Bohemia and later from carnotite deposits in the American West. When exceptionally rich uranium ore was discovered in the Katanga region of the Belgian Congo, two Belgian companies monopolized both the mining and the refining. The Union Minière du Haut Katanga controlled extraction, and the Société Générale Métallurgique de Hoboken handled the production of pure radium.2Environment International. The origin and early development of the Belgian radium industry This duopoly gave Belgium an outsized grip on the global radium supply through the 1920s and 1930s.
The effect on price was predictable. When a single supply chain controls virtually all production, prices stay high even as extraction becomes more efficient. American miners who had been producing radium from Colorado ores were largely undercut once the Congolese deposits came online, because the African ore was dramatically richer in uranium content. Yet the Belgian monopoly kept retail prices well above what a competitive market would have produced. Hospitals, researchers, and the booming radium-dial painting industry all paid a premium set by a handful of corporate gatekeepers.
The monopoly eventually lost its relevance not because competitors broke through, but because the world stopped needing radium in the same way. Once nuclear reactors became operational in the 1940s, artificially produced isotopes like cobalt-60 and cesium-137 could do many of the same jobs more cheaply and with more controllable radiation characteristics. The commercial radium market quietly collapsed.
Why There Is No Open Market Price Today
If you search for a current per-gram price of radium-226 (the most common isotope), you will not find one listed on any commodity exchange. Radium is a regulated radioactive material in virtually every country. In the United States, possessing radium-226 requires a specific license from the relevant state radiation control program or, in some cases, the Nuclear Regulatory Commission. You cannot order it from a chemical supplier the way you might order a gram of, say, platinum or palladium.
Small sealed sources containing tiny quantities of radium-226 do still exist, mostly as legacy items in medical facilities, old industrial gauges, and research labs. When these sources reach the end of their useful life, disposing of them is itself expensive. Specialized waste brokers handle radium sources, and the cost of proper disposal can run from a few hundred to several thousand dollars per source, depending on activity level and containment condition. In other words, the economics of radium have inverted: rather than paying to acquire it, owners now pay to get rid of it safely.
For researchers who need radium for specialized experiments, procurement typically happens through government-affiliated isotope programs or legacy stockpiles managed by national laboratories. These transfers are tracked, documented, and heavily regulated. There is no price discovery mechanism resembling a market because there are too few buyers, too few sellers, and too many regulatory barriers for anything like a spot price to form.
Radium-223 as a Modern Pharmaceutical
The one place radium carries a clear, trackable cost in the modern economy is in the pharmaceutical world. Radium-223 dichloride, sold under the brand name Xofigo, is an alpha-emitting radiopharmaceutical approved for treating metastatic castration-resistant prostate cancer that has spread to bone. Unlike radium-226, which is a naturally occurring isotope with a half-life of about 1,600 years, radium-223 has a half-life of roughly 11 days, which makes it practical for targeted therapy: it delivers its radiation dose quickly and then decays away.
The cost is substantial. Over a three-year period studied in the U.S. Medicare population, the Centers for Medicare and Medicaid Services spent more than $133 million on radium-223 therapy.3Journal of Nuclear Medicine. Utilization and Cost of Radium-223 Dichloride (Xofigo®) for Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPR) in the U.S. Medicare Population A standard course of treatment consists of six intravenous injections given once a month, and the drug cost alone for the full course has historically landed in the range of $50,000 to $70,000 in the U.S., though totals vary depending on the facility, insurance arrangements, and whether the patient completes all six doses.
Health technology assessments in Europe have wrestled with whether that expense is justified. Analyses across several countries pegged the cost per quality-adjusted life year at roughly €80,000 to €94,000, and most concluded that reimbursement was either not recommended or that no definitive statement could be made about cost-effectiveness.4PubMed Central. Health Economics and Radium-223 (Xofigo®) in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Case History and a Systematic Review of the Literature That ambivalence reflects a broader tension in oncology drug pricing: the clinical benefit exists, but the incremental survival gain is modest enough that health economists struggle to call it a good deal at the listed price.
It is worth noting that the cost of Xofigo is not really the “cost of radium” in the way someone asking the original question probably means. The price reflects the pharmaceutical development, manufacturing under strict radiopharmaceutical conditions, regulatory approval, distribution in lead-shielded containers with tight expiry windows, and the usual markup structure of branded oncology drugs. The radium-223 isotope itself is produced in reactors by irradiating other elements, and its raw material cost is a small fraction of the retail price.
Why Medicine Moved Away from Radium-226
For decades in the early-to-mid twentieth century, radium-226 was the workhorse isotope in radiation therapy, particularly in brachytherapy, where sealed radioactive sources are placed inside or next to a tumor. Radium needles and tubes were standard equipment in cancer clinics worldwide. But radium-226 had serious drawbacks: it produces radon gas as a decay product, creating a contamination hazard if a source leaks; it has an extremely long half-life, meaning disposal is a centuries-long problem; and the gamma radiation it emits requires heavy shielding.
Reactor-produced isotopes gradually replaced it. Cobalt-60 and iridium-192 became the dominant brachytherapy sources by the late twentieth century. Cobalt-60 in particular offered a compelling economic case in many settings. One analysis of the American brachytherapy market found that switching from iridium-192 to cobalt-60 sources could produce annual savings on the order of $52,000 per facility, mainly through reduced source-replacement frequency, since cobalt-60 has a longer half-life and does not need to be swapped out as often.5Journal of Contemporary Brachytherapy. Cost in perspective: direct assessment of American market acceptability of Co-60 in gynecologic high-dose-rate brachytherapy and contrast with experience abroad Radium-226 was not even part of the comparison anymore; by the time these cost analyses were being conducted, radium had already exited the clinical stage.
The transition was not purely about price. Safety drove much of the shift. Radium-226 sources age poorly. Over decades, metal capsules corrode, and even a microscopic breach can release radon and radioactive daughter products into a treatment room. Several well-documented contamination incidents at hospitals accelerated the move to safer alternatives. Today, finding a radium-226 brachytherapy source in an active clinic would be extraordinary; it would almost certainly be a forgotten legacy source rather than something in clinical use.
The Illicit Trade Angle
When a substance has no legal open market, questions about its “real” cost sometimes point toward the black market. Radium-226 has indeed appeared in illicit trafficking, though it is far less prominent in seizure records than enriched uranium or other fissile materials. International monitoring shows that natural radionuclides subject to trafficking include natural uranium ore, processed uranium in various enrichment grades, radium-226, polonium-210, and natural thorium.6AIP Publishing. Illicit Trafficking of Natural Radionuclides
The motives behind radium trafficking are mixed. Some incidents involve scrap dealers who stumble onto old industrial or medical sources and try to sell them without understanding what they have. Others involve deliberate attempts to profit from the mystique surrounding radioactive materials. In either case, “prices” in illicit transactions are erratic and not representative of any underlying value. A trafficker asking $50,000 for a vial of radium-226 is not pricing based on production cost or market fundamentals; they are pricing based on what they think a buyer will pay for something rare, dangerous, and hard to obtain legally.
From a security standpoint, radium-226 is considered a lower proliferation risk than enriched uranium or plutonium because it cannot sustain a nuclear chain reaction. The concern is more about radiological dispersal devices, where any sufficiently radioactive material could be used to contaminate an area. Regulatory tracking of radium sources exists partly for this reason, and the disposal infrastructure, while expensive, serves a dual purpose of keeping legacy sources out of uncontrolled hands.
Antique Radium Products and Collector Curiosities
One corner of the market where radium does change hands, in a sense, is the antique and curiosity trade. Radium-painted watch dials, quack medical devices like the Revigator (a radium-lined water crock), and vintage radium-containing patent medicines occasionally appear at estate sales, on auction sites, and in antique shops. These items contain vanishingly small amounts of radium-226, typically in the range of micrograms or less, but they are still radioactive.
Prices for these objects reflect collectibility, historical interest, and condition rather than the value of the radium inside them. A radium-dial military watch from World War II might sell for a few hundred dollars; a well-preserved Revigator crock might fetch several hundred to over a thousand. Buyers are usually collectors of scientific or medical oddities, not people trying to acquire radium as a material. Legally, these items occupy a gray area: in many jurisdictions, radium-containing consumer products manufactured before modern regulations are exempt from licensing requirements as long as they are not tampered with or deliberately concentrated. But the rules vary by country and sometimes by state, and sellers do not always know or disclose the radioactive content.
The radium in these objects is functionally worthless as a raw material. Extracting it would require chemical processing that is both illegal without a license and pointless given the tiny quantities involved. What the collector market does illustrate is that radium retains a cultural fascination that far outlasts its practical relevance. People are willing to pay a premium for a glowing watch dial not because of what radium can do for them, but because of what it represents: an era when radioactivity was synonymous with progress, health, and energy, before the dangers became impossible to ignore.
The Hidden Cost of Radium Contamination
Perhaps the most meaningful “cost” of radium in the twenty-first century is not the price of acquiring it but the price of cleaning it up. Former radium processing sites, luminous-dial painting factories, and medical facilities that used radium sources have left a legacy of contaminated land and buildings across the United States and Europe. The EPA has listed several radium-contaminated sites on the Superfund National Priorities List, and remediation costs run into the tens of millions of dollars per site.
The challenge with radium contamination is persistence. Radium-226 has a half-life of roughly 1,600 years, which means that soil or building materials contaminated during the 1920s radium boom are still nearly as radioactive today as they were a century ago. Cleanup typically involves excavating contaminated soil to a specified depth, transporting it to a licensed radioactive waste disposal facility, and backfilling with clean material. For buildings, it can mean demolition. The costs scale with the volume of contaminated material, and radium has a tendency to migrate through soil via groundwater, spreading the contamination footprint over time.
Some of the most expensive cleanups involve sites where radium was processed industrially. In these locations, residues from chemical extraction were often dumped on-site or used as fill material in nearby construction, spreading contamination to residential neighborhoods. Homeowners have discovered, sometimes decades after purchase, that their properties sit on radium-contaminated fill. The financial and personal toll of these discoveries, including plummeting property values, health anxiety, and years-long remediation timelines, represents a cost of radium that no historical price per gram ever captured.